Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
life sciences
national blog main
bristol-myers squibb
cancer
cancer immunotherapy
national
novartis
samit hirawat
adeno-associated virus
alexandria venture investments
altitude life science ventures
american society of gene and cell therapy
arch venture partners
boston blog main
boston top stories
boxer capital
deals
dravet syndrome
ed kaye
encoded therapeutics
gene therapy
generation bio
hemophilia
illumina
illumina ventures
matrix capital management
menlo ventures
national top stories
new york blog main
new york top stories
regulatory elements
rna
rtw investments
san diego blog main
san diego top stories
san francisco
san francisco blog main
san francisco top stories
sean nolan
What
progress
3
×
acquisition
anniversary
approaches
bn
bristol
celgene
chief
clinical
company’s
corporation
diversity
hirawat
medical
myers
myers’s
officer
pipeline
scrip
spoke
squibb
trial
year
crude
cutting
despite
edge
effects
encoded
gene
help
illumina’s
lasting
limited
limits
long
medicine
nabs
promising
push
Language
unset
Current search:
progress
×
biotech
×
@xconomy.com
3 years ago
Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity
@xconomy.com
3 years ago
Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits